[1]
|
Song, Y., Liu, X., Cheng, W., et al. (2022) The Global, Regional and National Burden of Stomach Cancer and Its Attributable Risk Factors from 1990 to 2019. Scientific Reports, 12, Article No. 11542. https://doi.org/10.1038/s41598-022-15839-7
|
[2]
|
Zhao, X., Liu, X., Tang, P., et al. (2009) The Extent and Value of Lymphadenectomy in Treating Gastroesophageal Junction Carcinoma. The Chinese-German Journal of Clinical Oncology, 8, 438-442. https://doi.org/10.1007/s10330-009-0086-7
|
[3]
|
Hosoda, K., Yamashita, K., Moriya, H., Mieno, H. and Watanabe, M. (2017) Optimal Treatment for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junction: A Retrospective Cohort Study with Long-Term Follow-Up. World Journal of Gastroenterology, 23, 2723-2730. https://doi.org/10.3748/wjg.v23.i15.2723
|
[4]
|
Huang, C.M. and Zheng, C.H. (2015) Laparoscopic Gastrectomy for Gastric Cancer. Springer, New York. https://doi.org/10.1007/978-94-017-9873-0
|
[5]
|
Nishiwaki, N., Noma, K., Matsuda, T., et al. (2020) Risk Factor of Mediastinal Lymph Node Metastasis of Siewert Type I and II Esophagogastric Junction Carcinomas. Langenbeck’s Archives of Surgery, 405, 1101-1109. https://doi.org/10.1007/s00423-020-02017-4
|
[6]
|
Chen, X.D., He, F.Q., Chen, M. and Zhao, F.Z. (2020) Incidence of Lymph Node Metastasis at Each Station in Siewert Types Ⅱ/Ⅲ Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta-Analysis. Surgical Oncology, 35, 62-70. https://doi.org/10.1016/j.suronc.2020.08.001
|
[7]
|
Li, Z.L., Zhao, L.Y., Zhang, W.H., et al. (2022) Clinical Significance of Lower Perigastric Lymph Nodes Dissection in Siewert Type II/III Adenocarcinoma of Esophagogastric Junction: A Retrospective Propensity Score Matched Study. Langenbeck’s Archives of Surgery, 407, 985-998. https://doi.org/10.1007/s00423-021-02380-w
|
[8]
|
Liang, R., Bi, X., Fan, D., Du, Q., Wang, R. and Zhao, B. (2022) Mapping of Lymph Node Dissection Determined by the Epicenter Location and Tumor Extension for Esophagogastric Junction Carcinoma. Frontiers in Oncology, 12, Article 913960. https://doi.org/10.3389/fonc.2022.913960
|
[9]
|
Kurokawa, Y., Takeuchi, H., Doki, Y., et al. (2021) Mapping of Lymph Node Metastasis from Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study. Annals of Surgery, 274, 120-127. https://doi.org/10.1097/SLA.0000000000003499
|
[10]
|
Yoshikawa, T., Takeuchi, H., Hasegawa, S., et al. (2016) Theoretical Therapeutic Impact of Lymph Node Dissection on Adenocarcinoma and Squamous Cell Carcinoma of the Esophagogastric Junction. Gastric Cancer, 19, 143-149. https://doi.org/10.1007/s10120-014-0439-y
|
[11]
|
Yabusaki, H., Nashimoto, A., Matsuki, A. and Aizawa, M. (2014) Comparison of the Surgical Treatment Strategies for Siewert Type II Squamous Cell Carcinoma in the Same Area as Esophagogastric Junction Carcinoma: Data from a Single Japanese High-Volume Cancer Center. Surgery Today, 44, 1522-1528. https://doi.org/10.1007/s00595-013-0773-4
|
[12]
|
Zheng, Z., Zhang, H.Q., Xu, R., et al. (2020) Assessment of Risk Factors of Lymph Node Metastasis and Prognosis of Siewert II/III Adenocarcinoma of Esophagogastric Junction: A Retrospective Study. https://doi.org/10.21203/rs.2.23871/v1
|
[13]
|
Shu, P., Sun, X., Liu, F., Fang, Y., Shen, K., Sun, Y., Qin, J. and Qin, X. (2021) Pattern of No. 12a Lymph Node Metastasis in Gastric Cancer. Chinese Journal of Cancer Research, 33, 61-68. https://doi.org/10.21147/j.issn.1000-9604.2021.01.07
|
[14]
|
Galizia, G., Lieto, E., De Vita, F., Castellano, P., Ferraraccio, F., Zamboli, A., Mabilia, A., Auricchio, A., De Sena, G., De Stefano, L., Cardella, F., Barbarisi, A. and Orditura, M. (2015) Modified versus Standard D2 Lymphadenectomy in Total Gastrectomy for Nonjunctional Gastric Carcinoma with Lymph Node Metastasis. Surgery, 157, 285-296. https://doi.org/10.1016/j.surg.2014.09.012
|
[15]
|
Yang, K., Chen, H.N., Liu, K., Zhang, W.H., Chen, X.Z., Chen, X.L., Zhou, Z.G. and Hu, J.K. (2016) The Survival Benefit and Safety of No. 12a Lymphadenectomy for Gastric Cancer Patients with Distal or Total Gastrectomy. Oncotarget, 7, 18750-18762. https://doi.org/10.18632/oncotarget.7930
|
[16]
|
Cai, S.R., Chen, J.H., Chen, C.Q., Wu, K.M., Zhang, X.H., Song, W. and He, Y.L. (2015) Survival of Proper Hepatic Artery Lymph Node Metastasis in Patients with Gastric Cancer: Implications for D2 Lymphadenectomy. PLOS ONE, 10, e0118953. https://doi.org/10.1371/journal.pone.0118953
|
[17]
|
Motoori, M., Kurokawa, Y., Takeuchi, H., et al. (2022) Risk Factors for Para-Aortic Lymph Node Metastasis in Esophagogastric Junction Cancer: Results from a Prospective Nationwide Multicenter Study. Annals of Surgical Oncology, 29, 5649-5654. https://doi.org/10.1245/s10434-022-11792-x
|
[18]
|
Sasako, M., Sano, T., Yamamoto, S., Sairenji, M., Arai, K., Kinoshita, T., Nashimoto, A., Hiratsuka, M. and Japan Clinical Oncology Group (JCOG9502) (2006) Left Thoracoabdominal Approach versus Abdominal-Transhiatal Approach for Gastric Cancer of the Cardia or Subcardia: A Randomised Controlled Trial. The Lancet Oncology, 7, 644-651. https://doi.org/10.1016/S1470-2045(06)70766-5
|
[19]
|
Kurokawa, Y., Sasako, M., Sano, T., Yoshikawa, T., Iwasaki, Y., Nashimoto, A., Ito, S., Kurita, A., Mizusawa, J., Nakamura, K. and Japan Clinical Oncology Group (JCOG9502) (2015) Ten-Year Follow-Up Results of a Randomized Clinical Trial Comparing Left Thoracoabdominal and Abdominal Transhiatal Approaches to Total Gastrectomy for Adenocarcinoma of the Oesophagogastric Junction or Gastric Cardia. British Journal of Surgery, 102, 341-348. https://doi.org/10.1002/bjs.9764
|
[20]
|
Shiraishi, O., Yasuda, T., Kato, H., et al. (2020) Risk Factors and Prognostic Impact of Mediastinal Lymph Node Metastases in Patients with Esophagogastric Junction Cancer. Annals of Surgical Oncology, 27, 4433-4440. https://doi.org/10.1245/s10434-020-08579-3
|
[21]
|
Suh, Y.S., Lee, K.G., Oh, S.Y., et al. (2017) Recurrence Pattern and Lymph Node Metastasis of Adenocarcinoma at the Esophagogastric Junction. Annals of Surgical Oncology, 24, 3631-3639. https://doi.org/10.1245/s10434-017-6011-3
|
[22]
|
Kurokawa, Y., Hiki, N., Yoshikawa, T., et al. (2015) Mediastinal Lymph Node Metastasis and Recurrence in Adenocarcinoma of the Esophagogastric Junction. Surgery, 157, 551-555. https://doi.org/10.1016/j.surg.2014.08.099
|
[23]
|
Mine, S., Watanabe, M., Kumagai, K., Okamura, A., Yuda, M., Hayami, M., Yamashita, K., Imamura, Y. and Ishizuka, N. (2019) Comparison of Mediastinal Lymph Node Metastases from Adenocarcinoma of the Esophagogastric Junction versus Lower Esophageal Squamous Cell Carcinoma with Involvement of the Esophagogastric Junction. Diseases of the Esophagus, 32, doz002. https://doi.org/10.1093/dote/doz002
|
[24]
|
Rüdiger Siewert, J., Feith, M., Werner, M. and Stein, H.J. (2000) Adenocarcinoma of the Esophagogastric Junction: Results of Surgical Therapy Based on Anatomical/Topographic Classification in 1002 Consecutive Patients. Annals of Surgery, 232, 353-361. https://doi.org/10.1097/00000658-200009000-00007
|
[25]
|
Hosoda, K., Yamashita, K., Katada, N., Moriya, H., Mieno, H., Sakuramoto, S., Kikuchi, S. and Watanabe, M. (2015) Impact of Lower Mediastinal Lymphadenectomy for the Treatment of Esophagogastric Junction Carcinoma. Anticancer Research, 35, 445-456.
|
[26]
|
Kakeji, Y., Yamamoto, M., Ito, S., et al. (2012) Lymph Node Metastasis from Cancer of the Esophagogastric Junction, and Determination of the Appropriate Nodal Dissection. Surgery Today, 42, 351-358. https://doi.org/10.1007/s00595-011-0114-4
|
[27]
|
Yamashita, H., Seto, Y., Sano, T., et al. (2017) Results of a Nation-Wide Retrospective Study of Lymphadenectomy for Esophagogastric Junction Carcinoma. Gastric Cancer, 20, 69-83. https://doi.org/10.1007/s10120-016-0663-8
|
[28]
|
Ding, B., Yong, J., Zhang, L., et al. (2022) Impact of Examined Lymph Node Number on Accurate Nodal Staging and Long-Term Survival of Resected Siewert Type II-III Adenocarcinoma of the Esophagogastric Junction: A Large Population-Based Study. Frontiers in Oncology, 12, Article 979338. https://doi.org/10.3389/fonc.2022.979338
|
[29]
|
Japanese Gastric Cancer Association (2023) Japanese Gastric Cancer Treatment Guidelines 2021 (6th Edition). Gastric Cancer, 26, 1-25. https://doi.org/10.1007/s10120-022-01331-8
|
[30]
|
Li, S., Ying, X., Shan, F., Jia, Y., Li, Z., Xue, K., Miao, R., Wang, Y., Bu, Z., Su, X., Li, Z. and Ji, J. (2022) Laparoscopic vs. Open Lower Mediastinal Lymphadenectomy for Siewert Type II/III Adenocarcinoma of Esophagogastric Junction: An Exploratory, Observational, Prospective, Thoracic Lymph Node Involvement in Adenocarcinoma of IDEAL Stage 2b Cohort Study (CLASS-10 Study). Chinese Journal of Cancer Research, 34, 406-414. https://doi.org/10.21147/j.issn.1000-9604.2022.04.08
|
[31]
|
李双喜, 李子禹. 食管胃结合部腺癌腹腔镜手术的下纵隔淋巴结清扫边界及质量控制[J]. 中华胃肠外科杂志, 2022, 25(2): 120-123.
|